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ABSTRACT 37 
Background: 38 
The objective of routine outpatient assessment of well functioning patients after primary total hip 39 
arthroplasty (THA) is to detect asymptomatic failure of prostheses to guide recommendations for early 40 
intervention. We have observed that the revision of THAs in asymptomatic patients is highly 41 
uncommon. We therefore question the need for routine follow-up of patients after THA.  42 
 43 
Methods: 44 
A prospective analysis of an orthopaedic database identified 158 patients who received 177 revision 45 
THAs over a 4 year period. A retrospective chart review was conducted. Patient demographics, primary 46 
and revision surgery parameters and follow-up information was recorded and cross referenced with 47 
AOA NJRR data. 48 
 49 
Results: 50 
110 THAs in 104 patients (average age 70.4 (SD 9.8 years). There were 70 (63.6%) total, 13 (11.8%) 51 
femoral and 27 (24.5%) acetabular revisions. The indications for revision were aseptic loosening 52 
(70%), dislocation (8.2%), peri-prosthetic fracture (7.3%), osteolysis (6.4%) and infection (4.5%). Only 53 
4 (3.6%) were asymptomatic revisions. A mean of 5.3 (SD 5.2 and 1.9 (SD 5.3 follow-up appointments 54 
were required before revision in patients with and without symptoms, respectively. The average time 55 
from the primary to revision surgery was 11.8 (SD 7.23) years. 56 
 57 
Conclusions: 58 
We conclude that patients with prostheses with excellent long term clinical results as validated by Joint 59 
Registries, routine follow-up of asymptomatic THA should be questioned and requires further 60 
investigation. Based on the work of this study, the current practice of routine follow-up of 61 
asymptomatic THA may be excessively costly and unnecessary and a less resource-intensive review 62 
method may be more appropriate. 63 
 64 
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INTRODUCTION 68 
Total hip arthroplasty (THA) is one of the most commonly performed operations in the western world1. 69 
In Australia, the Australian Orthopaedic Association (AOA) National Joint Replacement Registry 70 
(NJRR) reports that approximately 19,000 THAs are performed annually2. Unfortunately, for various 71 
reasons, the primary joint replacement does not always outlive the patient. Subsequent revision THA 72 
surgery is more technically difficult. It is usually performed in patients with more comorbidities, and 73 
does not offer functional results or quality of life as good as the primary THA whilst leading to 74 
significant costs to society3,4. Monitoring asymptomatic patients after primary THA has traditionally 75 
been conducted to detect early failure of the prosthesis and to guide recommendations and interventions 76 
where necessary. 77 
 78 
In September 2006, the Arthroplasty Society of Australia (ASA) released a position statement on the 79 
long term follow-up of hip and knee arthroplasties5. It predicted that in the next decade, the number of 80 
arthroplasties per annum will double and as such it is becoming increasingly difficult to regularly 81 
review all total joint replacements given the anticipated increase in demand for arthroplasty surgery. 82 
The ASA recommended that although follow-up of arthroplasty patients is necessary, reviews should 83 
be minimised where possible. Currently the Australian Orthopaedic Association (AOA) guidelines 84 
recommend follow-up of total knee and hip replacements at 3 months post-operatively, at 1-2 years, 10 85 
years and biennially thereafter. It is important to note that these guidelines are empiric and further 86 
research needs to be performed to be able to recommend a follow-up regime for patients undergoing 87 
TJA. 88 
 89 
Resource utilisation and cost-effectiveness of routine follow-up following primary THA is difficult to 90 
assess. To the knowledge of the authors, there is no information in the current literature that assesses 91 
the yield of routine outpatient assessment of well functioning, asymptomatic patients after primary 92 
THA. Givon et al. in 1998 performed an audit of outpatient follow-up of hip and knee arthroplasties 93 
and demonstrated a low yield of problematic joint replacement6. If detection of asymptomatic failure of 94 
the prosthesis is required to guide recommendations for early intervention, then a protocol of follow-up 95 
reviews should direct best current management based on the cost and time involved in reviewing 96 
asymptomatic patients. The aim of this study is to look at revision surgery undertaken at a tertiary 97 
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referral arthroplasty centre and to determine the incidence of asymptomatic patients undergoing 98 
revision THR. 99 
 100 
Significant resources and financial expenditure are involved in the regular review of asymptomatic 101 
patients after THA. The clinics in which post arthroplasty patients are reviewed, traditionally require 102 
staffing by medical and nursing staff and radiology support. From a patient perspective, postoperative 103 
assessment of joint replacement often requires radiation exposure and inconvenience in terms of time 104 
and expense, with questionable compliance7. 105 
 106 
Controversy exists between lower limb orthopaedic surgeons as to the quantity and regularity of routine 107 
post-operative follow-up required. A large variation in not only the number and timing of follow-up 108 
appointments, but the nature of the appointments, has been shown in orthopaedic surgeons performing 109 
THAs8. Each individual surgeon decides a protocol of the timing of patient reviews during follow-up 110 
clinics in which they monitor the patient clinically and radiographically for signs or symptoms of 111 
prosthesis failure. Balance must be sought by the surgeon when planning the follow-up protocol in 112 
order to maximise efficiency of the health system and minimise the strain on patient and out patient 113 
clinics. 114 
 115 
MATERIALS AND METHODS 116 
Ethics approval was obtained by The Prince Charles Hospital Health Service District Orthopaedic 117 
Research and Data Management Unit through the Human Research & Ethics Committee prior to 118 
commencement of the project (Approval Number EC2006/2). Survival data was collected from a 119 
prospective orthopaedic clinical database (Orthowave™, Stryker, Michigan, USA) and medical charts 120 
and was cross-referenced with the AOA National Joint Replacement Registry (NJRR) data. 121 
 122 
A prospective analysis of an orthopaedic database at a large Australian tertiary teaching hospital was 123 
performed from January 2003 to December 2006. Patients were included in the study regardless of 124 
which institution performed the primary THA. Only the first stage was considered in staged revisions. 125 
Procedures were excluded if the revision arthroplasty was performed on a hip joint that was not a 126 
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primary THA: revision of a hemiarthoplasty or; ORIF or; previous revision THA; or the second or 127 
subsequent stage of a staged revision THA. 128 
 129 
Various parameters were recorded for each patient including: patient demographics, date and type of 130 
primary surgery performed, indication for primary THA, primary prosthesis parameters, date and type 131 
of revision surgery performed, indication for revision THA and revision prosthesis parameters. For 132 
each consultation between the date of primary THA and the date of revision THA, 3 parameters were 133 
recorded; the date, patient symptoms and notes to illustrate the clinical situation including the 134 
management plan. Patients reviewed at our institution all receive an x-ray at each appointment. 135 
 136 
RESULTS 137 
One hundred and ten revision THAs, performed in 104 patients, met the inclusion criteria and had 138 
complete medical records over the 4 year period. Fifty-four (49.1%) had the primary THA at our 139 
institution while 56 (50.9%) had the primary THA performed elsewhere. The primary THAs performed 140 
elsewhere were either referred from the General Practitioner with symptoms or referred by regional 141 
orthopaedic surgeons advising revisions that should be performed at a specialised centre. The cohort 142 
consisted of 61 males (55.5%) and 49 females (44.5%) with a combined average age of 70.4 (SD 9.8) 143 
years. 144 
 145 
Only 4 (3.6%) of revision THAs were performed for an asymptomatic indication (in 3 patients as one 146 
patient had bilateral revision THAs in the 4 year period). One of the 3 patients had the primary THA at 147 
the study centre.  148 
 149 
In the symptomatic group, the most common symptom reported in the first symptomatic follow-up visit 150 
was pain (75%) (Graph 1). Other symptoms were far less common and were almost always followed by 151 
pain in subsequent follow-up visits. There were 8.2% cases revised for dislocation and 6.4% for 152 
fracture, however these patients all presented to the Emergency Room or their GP with pain or 153 
instability and so would not have been asymptomatic at routine follow up. 154 
 155 
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A mean of 5.3 (SD 5.2, median 4, range 1-36) follow-up appointments were required before revision in 156 
patients with symptoms. In asymptomatic patients, a mean of 1.9 (SD 5.3, (median 0.5, range 1-15) 157 
follow-up appointments were required before revision surgery. The average time from the primary 158 
THA to revision THA in the sample was 141.6 (SD 86.76) months. The average time from primary to 159 
revision THA was 161.3 (SD 16.92) months in the asymptomatic group and 140.4 (SD 88.04) months 160 
in the symptomatic group. 161 
 162 
There were 70 total, 13 femoral and 27 acetabular revisions (table 1). The indications for revision 163 
surgery were well categorised. The majority (77) of revision THAs were for aseptic prosthetic 164 
loosening. Causes for revision are displayed in Table 2. 165 
 166 
The first asymptomatic case was of a 61 year old female who had bilateral non-cemented THAs for 167 
osteoarthritis performed elsewhere over a decade previously. She developed symptoms (most notably 168 
pain) in the right hip and following investigation of her right hip pain, pelvic X-rays showed a superior 169 
acetabular osteolytic lesion and severe poly wear on the contralateral left side. The right hip was 170 
revised first due to a large recurrent iliopsoas bursa secondary to marked polyethylene wear. After full 171 
recovery from the surgery and upon the surgeon’s recommendations, the patient elected to undergo an 172 
acetabular revision procedure on the left hip (Figure 2). 173 
 174 
The second asymptomatic case was of a 62 year old female who had bilateral cemented THAs for 175 
osteoarthritis performed at the study institution more than 15 years previously. The right hip was 176 
revised prior to the 4 year period and upon routine post-operative follow-up for the revised right hip, 177 
routine x-ray demonstrated a superior acetabular osteolytic lesion in the left hip. The surgeon elected to 178 
monitor the progress of the osteolytic lesion. 8 years after the onset of the osteolysis, the surgeon 179 
recommended revision of the acetabular component as the risk of fracture or gross prosthetic failure 180 
outweighed the risk of the revision procedure (Figure 3). 181 
 182 
The third and fourth asymptomatic revisions were both in a 68 year old obese gentleman who had 183 
bilateral cemented THAs performed elsewhere more than a decade previously for osteoarthritis. He was 184 
referred to our institution for investigation of left knee pain and routine pelvic radiographs showed 185 
global hip osteolysis and severe poly wear bilaterally. The surgeon elected to revise the right hip first 186 
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due to the severity of osteolysis and the inherent risk of fracture. The left hip was revised 7 months 187 
later after full recovery from the first revision. The surgeon remarked that clinically the knee pain was 188 
unlikely to be referred from the hip but he could not be certain. It was decided to include this hip in the 189 
asymptomatic group however the true pick up rate of asymptomatic hips requiring revision may be 190 
even less than 4% (Figure 4). 191 
 192 
DISCUSSION 193 
Of the 4 asymptomatic cases discussed, 3 of these revisions were deemed necessary following 194 
investigation for other comorbidities not directly related to the THA that was subsequently revised. It is 195 
of note that in no cases of 110 revisions did routine, elective follow-up of primary THAs result in the 196 
detection and subsequent revision of an asymptomatic joint. 197 
It is of note that symptomatic patients requiring revision had significantly more out patient visits. This 198 
is because once symptomatic, a patient is often carefully followed for progression of pain or osteolysis. 199 
Often mildly symptomatic patients can be followed over a number of years if there is no radiographic 200 
deterioration. Asymptomatic patients offered revision are those that present with significant bone loss 201 
and are at risk of fracture or more rapid osteolysis. These patients are prioritised for surgery. 202 
Currently approximately 19,000 THAs are performed in Australia per year1 and we can expect this 203 
figure to double within the next decade5. With this increase in demand, the routine follow-up of 204 
standard primary THAs is becoming more resource intensive. According to the data from this study, an 205 
extremely low pick-up rate of asymptomatic patients requiring revision arthroplasty was found. This 206 
may have substantial economic and resource implications. 207 
The majority (96.4%) of revision THAs performed on standard primary THAs were for symptomatic 208 
indications. It could be argued that if these patients were not followed-up on a routine basis they would 209 
have been referred back for investigation of their complaints upon failure of their arthroplasty. One of 210 
the weaknesses of our study is that those patients referred from other institutions did not have those 211 
charts reviewed to determine if there was any evidence of a failing prosthesis in the absence of 212 
symptoms. However, the majority were symptomatic (with pain) at their first appointment at our 213 
institution and with the low rate of asymptomatic problems in those with complete histories, it is 214 
unlikely that this would unduly influence the results. 215 
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 216 
In the future, as we can expect the arthroplasty demand to increase, should we continue to review all 217 
our THAs as regularly? Alternate methods of post-arthroplasty surveillance need exploring if we are to 218 
accommodate such an increase in demand. The establishment of the AOA NJRR and other such joint 219 
registries around the world are already providing invaluable information regarding implant survival. 220 
Other resources are being sought in providing appropriate post-arthroplasty follow-up and may be of 221 
some benefit in the near future9. 222 
 223 
Alternatives to outpatient attendance such as telephone interviewing schemes are being trialled as 224 
follow-up tools to reduce the economic and resource impact on the surgical community10. In patients 225 
after total knee or hip replacement, Sethuraman, McGuigan et al. found that patients believed that their 226 
care was not compromised by conducting follow-up by mailed questionnaires and radiographs11. 227 
 228 
Specific prostheses may need to be followed-up more vigorously if proven to be problematic. As data 229 
is continually collected, correlated and analysed via the AOA NJRR, information on individual 230 
prostheses is becoming evident demonstrating specific peaks at which complications arise with respect 231 
to time from the primary procedure. Using such information, specific and more tailored protocols for 232 
individual prostheses, based on joint registry survivorship data and long term complications may lead 233 
to a more time-, cost- and patient- effective model for routine follow-up following standard primary 234 
THA. 235 
 236 
In conclusion the authors encourage the exploration of less resource-intensive and more cost-effective 237 
review methods for the routine follow-up of primary THAs.  238 
 239 
240 
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Tables 241 
 242 
Table 1- Components Revised 243 
 n (%) Time to revision 
Av (months) 
SD (months) 
Global revision 70 (63.6) 154.4 90.63 
Acetabular revision 27 (24.5) 132.9 77.20 
Femoral Revision 13 (11.8) 89.2 67.58 
 244 
 245 
246 
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Table 2 – Indications for Revision 247 
 n (%) Time to revision 
Av (months) 
SD (months) 
Aseptic loosening 76 (69.1) 139.0 85.16 
 Global loosening  30 (27.3)  171.6  86.25 
 Cup loosening  30 (27.3)  156.8  77.81 
 Stem loosening  16 (14.5)  131.1  95.05 
Dislocation 9 (8.2) 99.2 117.04 
Femoral fracture 7 (6.4) 127.4 75.80 
Infection 5 (4.5) 27.0 29.15 
Cup osteolysis 4 (3.6) 112.8 60.36 
Femoral osteolysis 2 (1.8) 105.0 22.63 
Global osteolysis 2 (1.8) 155.0 7.07 
Cup wear 1 (0.9) 85  
Cup fracture 1 (0.9) 164  
Other 3 (2.7) 154.3 33.61 
 248 
 249 
250 
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Figure Legends 251 
Figure 1. Pie chart indicating first symptom reported at first symptomatic follow-up visit. 252 
Figure 2. Plain Radiograph of first asymptomatic case (left hip). 253 
Figure 3. Plain Radiograph of second asymptomatic case (left hip).  254 
Figure 4. Plain Radiograph of third case with bilateral asymptomatic hips. 255 
 256 
 257 
258 
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